Skip to main content
. 2016 Mar 18;52(1):113–131. doi: 10.1111/1475-6773.12479

Table 1.

Characteristics of Subjects Meeting Three Definitions of Serious Illness and Comparison Group

Criteria A Criteria B Criteria C Comparison Groupa
N 5,297 3,151 1,447 4,841b
Age, mean (SD), years 78.2 (8.4) 80.1 (8.4) 82.4 (8.4) 75.3 (6.9)
Female, n (%) 3,201 (60.4) 1,950 (61.9) 972 (67.2) 2,811 (58.1)
Race
Non‐Hispanic white, n (%) 3,993 (75.4) 2,389 (75.8) 1,070 (73.9) 4,039 (83.4)
African American, n (%) 812 (15.3) 497 (15.8) 241 (16.7) 470 (9.7)
Hispanic, n (%) 398 (7.5) 211 (6.7) 108 (7.5) 247 (5.1)
Other, n (%) 94 (1.8 54 (1.7) 28 (1.9) 85 (1.8)
Education
Less than high school degree, n (%) 1,899 (35.9) 1,183 (37.5) 621 (42.9) 1,004 (20.7)
High school degree/some college, n (%) 2,676 (50.5) 1,558 (49.4) 664 (45.9) 2,812 (58.1)
Four‐year college degree, n (%) 722 (13.6) 410 (13.0) 162 (11.2) 1,025 (21.2)
Self‐rated health, fair/poor, n (%) 3,139 (59.4) 2,092 (66.5) 1,103 (76.3) 1,177 (24.3)
Married, n (%) 2,432 (45.9) 1,227 (38.9) 467 (32.3) 2,810 (58.0)
Net worth, mean (SD) $408,704 ($1,006,942) $359,725 ($957,779) $285,472 ($842,234) $718,328 ($1,558,112)
Severe medical conditionsc
Alzheimer's/dementia, n (%) 1,177 (22.2) 960 (30.5) 813 (56.2) 0.0 (0.0)
Cancer, n (%) 474 (8.9) 240 (7.6) 87 (6.0) 0.0 (0.0)
End‐stage renal disease, n (%) 622 (11.7) 486 (15.4) 258 (17.8) 0.0 (0.0)
Congestive heart failure, n (%) 343 (6.5) 393 (12.5) 207 (14.3) 0.0 (0.0)
Chronic obstructive pulmonary disease, n (%) 783 (14.8) 608 (19.3) 281 (19.4) 0.0 (0.0)
Diabetes, n (%) 1,043 (19.7) 661 (21.0) 357 (24.7) 0.0 (0.0)
Liver disease, n (%) 296 (5.6) 121 (3.8) 47 (3.2) 0.0 (0.0)
Hip fracture, n (%) 158 (3.0) 177 (5.6) 121 (8.4) 0.0 (0.0)
Three or more comorbid conditionsd, n (%) 4,455 (84.1) 2,987 (94.8) 1,406 (97.2) 2,063 (42.6)
Functional status
Stable, independent in ADLs, n (%) 2,882 (54.6) 1,475 (47.1) 0 (0.0) 4,841 (100)
Stable, moderate debility (1–3 ADL impairments), n (%) 373 (7.1) 279 (8.9) 209 (14.6) 0.0 (0.0)
Stable, severe debility (4–6 ADL impairments), n (%) 187 (3.5) 175 (5.6) 155 (10.8) 0.0 (0.0)
Declined, independent to moderate, n (%) 1,310 (25.3) 648 (21.0) 536 (38.0) 0.0 (0.0)
Declined, independent to severe, n (%) 377 (7.3) 371 (12.0) 354 (25.1) 0.0 (0.0)
Declined, moderate to severe, n (%) 147 (2.8) 183 (5.9) 181 (12.8) 0.0 (0.0)
Characteristic meeting criteria
Any serious medical condition, n (%) 4,004 (75.6) 2,634 (83.6) 1,447 (100) 0.0 (0.0)
Functional impairment, n (%) 2,408 (45.5) 1,670 (53.0) 1,447 (100) 0.0 (0.0)
Medical condition and functional impairment, n (%) 1,115 (21.0) 1,153 (36.6) 1,447 (100) 0.0 (0.0)
Nursing home resident, n (%) 725 (13.7) 926 (29.4) 750 (51.8) 31 (0.6)
Hospital admission, n (%) 2,077 (39.2) 2,671 (84.8) 1,118 (77.3) 389 (8.0)

Criteria A = Condition and/or Functional Limitation. Criteria B = Condition and/or Functional Limitation and Utilization. Criteria C = Condition and Functional Limitation and Utilization. Comparison Group = Subjects not meeting any serious illness criteria.

Bold indicates the subjects' characteristics, which meet the criteria for each definition.

a

Subjects in the Comparison group differ significantly (p < .05) on all characteristics compared to those in Criteria A, B and C, respectively, except “Other” Race.

b

Due to cross‐sectional enrollment of the Comparison group, the size of this group cannot be directly compared to the other groups.

c

ALS and AIDS not reported due to HRS guidelines on cell size reporting restrictions.

d

Comorbid conditions were identified in Medicare claims (Elixhauser et al. 1998).